Peering Into Vertex Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Vertex Pharmaceuticals' (NYSE:VRTX) short percent of float has risen 13.27% since its last report, with 2.86 million shares sold short, which is 1.11% of all regular shares available for trading. It would take traders 2.11 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. Vertex Pharmaceuticals' peer group average for short interest as a percentage of float is 3.21%, which means the company has less short interest than most of its peers.
August 18, 2023 | 6:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The increase in short interest in Vertex Pharmaceuticals could indicate a bearish sentiment among investors. However, compared to its peers, the company has less short interest.
The increase in short interest in Vertex Pharmaceuticals indicates that more investors are betting that the company's stock price will fall. This could put downward pressure on the stock price in the short term. However, the company's short interest is less than its peers, which could indicate that it is less likely to experience a significant price drop compared to other companies in the same industry.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100